Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Ecology Letters|January 10, 2018
Thermal biology mediates responses of amphibians and reptiles to habitat modificationA Justin Nowakowski, James I Watling, Michelle E Thompson, et al.
JACC. Cardiovascular Interventions|March 17, 2021
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI TrialThomas Pilgrim, Olivier Muller, Dik Heg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2017
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trialJuan F Iglesias, Olivier Muller, Serge Zaugg, et al.
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.
Journal of the American Heart Association|March 17, 2016
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialRainer Zbinden, Raffaele Piccolo, Dik Heg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 21, 2016
First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosisPannipa Suwannasom, Yohei Sotomi, Roberto Corti, et al.
Lancet (London, England)|September 7, 2019
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trialJuan F Iglesias, Olivier Muller, Dik Heg, et al.
Swiss Medical Weekly|August 23, 2023
Association of chocolate consumption with neurological and cardiovascular outcomes in atrial fibrillation: data from two Swiss atrial fibrillation cohort studies (Swiss-AF and BEAT-AF)Annina Stauber, Andreas Müller, Nikki Rommers, et al.
Plos One|January 16, 2019
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE IIRaban V Jeger, Matthias Pfisterer, Deborah R Vogt, et al.
Heart Rhythm|August 23, 2024
Is electrical cardioversion independently associated with infarcts on brain magnetic resonance imaging or clinical outcomes in patients with atrial fibrillation?Annina Stauber, Andreas Müller, Nikki Rommers, et al.
Pageof 5